Episode Details

Back to Episodes
Holiday greetings, multiple long-term conditions for people with diabetes, dasiglucagon therapy for postprandial hypoglycemia after gastric bypass, light-dark and activity-rest rhythms and glucose metabolism, and more!

Holiday greetings, multiple long-term conditions for people with diabetes, dasiglucagon therapy for postprandial hypoglycemia after gastric bypass, light-dark and activity-rest rhythms and glucose metabolism, and more!

Season 1 Episode 13 Published 2 years, 7 months ago
Description

Welcome to episode no. 13 (December 2023) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the December 2023 issue of Diabetes Care.  

1:45: Alice interviews Kamlesh Khunti, lead author of "Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge." This study is an editor-selected feature article appearing in the December 2023 issue and is openly accessible at https://doi.org/10.2337/dci23-0035.

18:10: Mike interviews Casper K. Nielsen, lead author of "Dasiglucagon Treatment for Postprandial Hypoglycemia After Gastric Bypass: A Randomized, Double-Blind, Placebo-Controlled Trial." This study is also an editor-selected feature article appearing in the December 2023 issue and is openly accessible at https://doi.org/10.2337/dc23-1193.

34:00: In the "Diabetes Care Rapid Exchange," Alice and Mike wrap up the episode by reviewing several interesting articles in the December 2023 issue of Diabetes Care. Studies highlighted in this segment include:

  • Xiao et al. Alignment Between 24-h Light-Dark and Activity-Rest Rhythms Is Associated With Diabetes and Glucose Metabolism in a Nationally Representative Sample of American Adults. https://doi.org/10.2337/dc23-1034    
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us